Clinical usefulness of measuring the content of amino acids modified by the Maillard reaction in vivo in acute cerebral infarction

Clinical usefulness of measuring the content of amino acids modified by the Maillard reaction in vivo in acute cerebral infarction - Clinical usefulness of measuring the content of amino acids modified by the Maillard reaction in vivo in acute cerebral infarction

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060108

Enrollment

200

Registered

2025-12-19

Start date

2025-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18 years or older 2. Subjects who are deemed to be thrombectomy recipients by a full-time physician at Fukuoka Neurosurgical Hospital 3. Subjects who have received sufficient information regarding participation in this study and have provided written consent of their own free will 4. Subjects who are unable to make their own decisions, and whose blood relatives have provided written consent

Exclusion criteria

Exclusion criteria: 1. Those whose thrombus could not be retrieved 2. Those who are otherwise deemed inappropriate by the principal investigator or investigator

Design outcomes

Primary

Measure	Time frame
Primary endpoint: Patient outcome (mRS) one month after surgery. Secondary endpoint: Improvement in NIHSS score 24 hours after surgery.	—

Countries

Japan

Contacts

Public ContactTakashi Fujii

Fukuoka Neurosurgical Hospital Department of Neurosurgery

takashigreengreen@gmail.com+81-92-558-0081

Outcome results